Your browser doesn't support javascript.
loading
Pathogenic NR2F1 variants cause a developmental ocular phenotype recapitulated in a mutant mouse model.
Jurkute, Neringa; Bertacchi, Michele; Arno, Gavin; Tocco, Chiara; Kim, Ungsoo Samuel; Kruszewski, Adam M; Avery, Robert A; Bedoukian, Emma C; Han, Jinu; Ahn, Sung Jun; Pontikos, Nikolas; Acheson, James; Davagnanam, Indran; Bowman, Richard; Kaliakatsos, Marios; Gardham, Alice; Wakeling, Emma; Oluonye, Ngozi; Reddy, Maddy Ashwin; Clark, Elaine; Rosser, Elisabeth; Amati-Bonneau, Patrizia; Charif, Majida; Lenaers, Guy; Meunier, Isabelle; Defoort, Sabine; Vincent-Delorme, Catherine; Robson, Anthony G; Holder, Graham E; Jeanjean, Luc; Martinez-Monseny, Antonio; Vidal-Santacana, Mariona; Dominici, Chloé; Gaggioli, Cedric; Giordano, Nadia; Caleo, Matteo; Liu, Grant T; Webster, Andrew R; Studer, Michèle; Yu-Wai-Man, Patrick.
Afiliación
  • Jurkute N; Moorfields Eye Hospital NHS Foundation Trust, London, UK.
  • Bertacchi M; Institute of Ophthalmology, University College London, London, UK.
  • Arno G; Université Côte d'Azur, CNRS, Inserm, iBV, Nice, France.
  • Tocco C; Moorfields Eye Hospital NHS Foundation Trust, London, UK.
  • Kim US; Institute of Ophthalmology, University College London, London, UK.
  • Kruszewski AM; Université Côte d'Azur, CNRS, Inserm, iBV, Nice, France.
  • Avery RA; Moorfields Eye Hospital NHS Foundation Trust, London, UK.
  • Bedoukian EC; Kim's Eye Hospital, Seoul, South Korea.
  • Han J; Department of Neurology, Hospital of the University of Pennsylvania, Perelman School of Medicine, Philadelphia, PA, USA.
  • Ahn SJ; Division of Ophthalmology, Children's Hospital of Philadelphia, Philadelphia, PA, USA.
  • Pontikos N; Department of Neurology, Perelman School of Medicine, Philadelphia, PA, USA.
  • Acheson J; Department of Ophthalmology, Perelman School of Medicine, Philadelphia, PA, USA.
  • Davagnanam I; Roberts Individualized Medical Genetics Center, Children's Hospital of Philadelphia, Philadelphia, PA, USA.
  • Bowman R; Institute of Vision Research, Department of Ophthalmology, Gangnam Severance Hospital, Yonsei University College of Medicine, Seoul, South Korea.
  • Kaliakatsos M; Department of Radiology, Gangnam Severance Hospital, Yonsei University College of Medicine, Seoul, South Korea.
  • Gardham A; Moorfields Eye Hospital NHS Foundation Trust, London, UK.
  • Wakeling E; Institute of Ophthalmology, University College London, London, UK.
  • Oluonye N; Moorfields Eye Hospital NHS Foundation Trust, London, UK.
  • Reddy MA; National Hospital for Neurology and Neurosurgery, University College London Hospitals NHS Trust, London, UK.
  • Clark E; Moorfields Eye Hospital NHS Foundation Trust, London, UK.
  • Rosser E; Department of Brain Repair & Rehabilitation, UCL Queen Square Institute of Neurology, London, UK.
  • Amati-Bonneau P; Department of Ophthalmology, Great Ormond Street Hospital for Children NHS Foundation Trust, London, UK.
  • Charif M; Paediatric Neurology, Great Ormond Street Hospital for Children NHS Foundation Trust, London, UK.
  • Lenaers G; North West Thames Regional Genetics Service, Northwick Park Hospital, Harrow, UK.
  • Meunier I; North East Thames Regional Genetics Service, Great Ormond Street Hospital for Children NHS Foundation Trust, London, UK.
  • Defoort S; Moorfields Eye Hospital NHS Foundation Trust, London, UK.
  • Vincent-Delorme C; Wolfson Neurodisability Service, Great Ormond Street Hospital NHS Foundation Trust, London, UK.
  • Robson AG; Moorfields Eye Hospital NHS Foundation Trust, London, UK.
  • Holder GE; Royal London Hospital, Barts Health NHS Trust, London, UK.
  • Jeanjean L; Department of Neuroscience, Great Ormond Street Hospital for Children NHS Foundation Trust, London, UK.
  • Martinez-Monseny A; Department of Clinical Genetics, Great Ormond Street Hospital for Children NHS Foundation Trust, London, UK.
  • Vidal-Santacana M; MitoLab Team, UMR CNRS 6015 - INSERM U1083, Institut MitoVasc, Angers University and Hospital, Angers, France.
  • Dominici C; Department of Biochemistry and Genetics, University Hospital Angers, Angers, France.
  • Gaggioli C; Genetics and Immuno-cell Therapy Team, Mohammed First University, Oujda, Morocco.
  • Giordano N; MitoLab Team, UMR CNRS 6015 - INSERM U1083, Institut MitoVasc, Angers University and Hospital, Angers, France.
  • Caleo M; National Center for Rare Diseases, Inherited Sensory Disorders, Gui de Chauliac Hospital, Montpellier, France.
  • Liu GT; MitoLab Team, UMR CNRS 6015 - INSERM U1083, Institut MitoVasc, Angers University and Hospital, Angers, France.
  • Webster AR; Service d'exploration de la vision et neuro-ophtalmologie, CHRU de Lille, Lille, France.
  • Studer M; Service de Génétique médicale, Hôpital Jeanne de Flandre, CHRU de Lille, Lille, France.
  • Yu-Wai-Man P; Moorfields Eye Hospital NHS Foundation Trust, London, UK.
Brain Commun ; 3(3): fcab162, 2021.
Article en En | MEDLINE | ID: mdl-34466801
ABSTRACT
Pathogenic NR2F1 variants cause a rare autosomal dominant neurodevelopmental disorder referred to as the Bosch-Boonstra-Schaaf Optic Atrophy Syndrome. Although visual loss is a prominent feature seen in affected individuals, the molecular and cellular mechanisms contributing to visual impairment are still poorly characterized. We conducted a deep phenotyping study on a cohort of 22 individuals carrying pathogenic NR2F1 variants to document the neurodevelopmental and ophthalmological manifestations, in particular the structural and functional changes within the retina and the optic nerve, which have not been detailed previously. The visual impairment became apparent in early childhood with small and/or tilted hypoplastic optic nerves observed in 10 cases. High-resolution optical coherence tomography imaging confirmed significant loss of retinal ganglion cells with thinning of the ganglion cell layer, consistent with electrophysiological evidence of retinal ganglion cells dysfunction. Interestingly, for those individuals with available longitudinal ophthalmological data, there was no significant deterioration in visual function during the period of follow-up. Diffusion tensor imaging tractography studies showed defective connections and disorganization of the extracortical visual pathways. To further investigate how pathogenic NR2F1 variants impact on retinal and optic nerve development, we took advantage of an Nr2f1 mutant mouse disease model. Abnormal retinogenesis in early stages of development was observed in Nr2f1 mutant mice with decreased retinal ganglion cell density and disruption of retinal ganglion cell axonal guidance from the neural retina into the optic stalk, accounting for the development of optic nerve hypoplasia. The mutant mice showed significantly reduced visual acuity based on electrophysiological parameters with marked conduction delay and decreased amplitude of the recordings in the superficial layers of the visual cortex. The clinical observations in our study cohort, supported by the mouse data, suggest an early neurodevelopmental origin for the retinal and optic nerve head defects caused by NR2F1 pathogenic variants, resulting in congenital vision loss that seems to be non-progressive. We propose NR2F1 as a major gene that orchestrates early retinal and optic nerve head development, playing a key role in the maturation of the visual system.
Palabras clave

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Tipo de estudio: Guideline Idioma: En Revista: Brain Commun Año: 2021 Tipo del documento: Article País de afiliación: Reino Unido

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Tipo de estudio: Guideline Idioma: En Revista: Brain Commun Año: 2021 Tipo del documento: Article País de afiliación: Reino Unido